NasdaqCM - Delayed Quote ? USD Spectral AI, Inc. (MDAIW) Follow Compare 0.1280 -0.0118 (-8.44%) At close: November 1 at 4:00 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers Milestone Achievement Supports Planned FDA Submission of DeepView AI?-Burn in 2025 DALLAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the final group of burn center patients in the Company’s U.S. Burn Pivotal Study have successfully completed their clinical visits. One of the largest d GlobeNewswire ? 2 days ago MDAI +2.08% MDAIW -8.44% Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2024 on Wednesday, November 6, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day GlobeNewswire ? 9 days ago MDAI +2.08% MDAIW -8.44% MDAI: Management Changes By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) announced a big change in its leadership ranks on October 14th. Founder Dr. J. Michael DiMaio returns as chairman of the Board of Directors and will guide the newly created Office of the Chairman (OC) to assume day to day operational responsibilities for running the company. The OC will Zacks Small Cap Research ? 10 days ago MDAIW -8.44% Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the Company's Founder, Dr. J. Michael DiMaio, has been named Chairman of the Board of Directors. “Our Board of Directors welcomes Dr. DiMaio back to the role of Spectral AI's Chairman. Given our needs for the future, the Board conclude GlobeNewswire ? 18 days ago MDAI +2.08% MDAIW -8.44% Spectral AI Completes Proof of Concept for Wound Measurement Technology Provides Clinicians with Superior Wound Size Measurement Information that Improves Patient Treatment DecisionsDALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the completion of a proof-of-concept module of its wound measurement technology that calculates the total body surface area (“TBSA GlobeNewswire ? 29 days ago MDAI +2.08% MDAIW -8.44% Spectral AI Achieves 25% Patient Enrollment at Emergency Departments?for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites DALLAS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has achieved 25% patient enrollment at Emergency Departments (“ED”) for its U.S. Burn Pivotal Study and added two new ED Clinical Trial Sites for this study: MedStar Washington Hospital Center in Washington, DC led by Principal Inv GlobeNewswire ? last month MDAI +2.08% MDAIW -8.44% Spectral AI Outlines U.S. Regulatory Pathway for DeepView??System for Burn Indication DALLAS, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today provided an outline of its regulatory pathway strategy to enter the U.S. market with its flagship DeepView? System for burn indication (“DeepView AI?-Burn”). DeepView AI?-Burn, which received Breakthrough Device Designation from the U.S. Food and Dr GlobeNewswire ? last month MDAI +2.08% MDAIW -8.44% American Burn Association Study Highlights Inequities in Access to Specialized Burn Care Spectral AI’s DeepView? System Designed to Provide Equity in Burn Care Access While Optimizing Healthcare ResourcesDALLAS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today provided an overview of a study conducted by the American Burn Association (“ABA”) highlighting the physical and economic barriers to GlobeNewswire ? last month MDAI +2.08% MDAIW -8.44% Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium?to Support Ongoing Development of DeepView SnapShot M? Project Funding Exceeds $7.0 MillionDALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has received a new award of over $850,000 from the Medical Technology Enterprise Consortium (“MTEC”). This award will support the ongoing development of DeepView SnapShot M?, Spectral AI’s handhe GlobeNewswire ? last month MDAI +2.08% MDAIW -8.44% Spectral AI to Participate in Upcoming Investor Conferences DALLAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Peter M. Carlson, Chief Executive Officer, and Vince Capone, Chief Financial Officer, are scheduled to participate in the following investor conferences in New York City: H.C. Wainwright 26th Annual Global Investment Conference Septemb GlobeNewswire ? 2 months ago MDAI +2.08% MDAIW -8.44% Spectral AI hits enrollment goal at burn centres for AI-powered assessment tech Emergency department enrolment will continue into 2025 for a subsequent and separate 510(k) application. Clinical Trials Arena ? 2 months ago MDAIW -8.44% Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study Milestone Achievement Advances Commercialization Timeline for DeepView? System for Burn IndicationDALLAS, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the completion of adult and pediatric patient enrollment at U.S. burn centers for its U.S. Burn Pivotal Study. One of the largest domestic bur GlobeNewswire ? 2 months ago MDAI +2.08% MDAIW -8.44% Spectral AI Announces Podium Presentation at BBA / ISBI Joint Conference?Assessing Burn Wound Severity Using Multispectral Imaging and Artificial Intelligence DALLAS, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Dr. Jeffrey Carter will present data from an ongoing prospective multicenter study analyzing the use of Spectral AI’s DeepView? System, which utilizes non-invasive multispectral imaging technology and proprietary AI, to detect non-heal GlobeNewswire ? 2 months ago MDAI +2.08% MDAIW -8.44% MDAI: Second Quarter Results By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) reported second quarter results on August 12th, 2024. Revenues totaled $7.5 million and the burn trial is now 85% enrolled. The company recently signed a collaboration agreement with Australia’s PolyNovo which may extend the use of DeepView down under. Management outlined the pathway forward Zacks Small Cap Research ? 2 months ago MDAIW -8.44% Earnings Release: Here's Why Analysts Cut Their Spectral AI, Inc. (NASDAQ:MDAI) Price Target To US$5.35 It's been a pretty great week for Spectral AI, Inc. ( NASDAQ:MDAI ) shareholders, with its shares surging 12% to... Simply Wall St. ? 2 months ago MDAI +2.08% MDAIW -8.44% Spectral AI Announces 2024 Second Quarter Financial Results Second Quarter Revenue Totals $7.5 Million Total Enrollment Exceeds 85% for Burn Center Pivotal U.S. Clinical Trial Q2 2024 Overview Research & Development Revenue of $7.5 MillionCash Position of $6.9 MillionOn Track to Generate First Commercial Revenues in the U.K. Later this YearBurn Pivotal Study Nearing Completion Paving the Way for U.S. FDA Submission in Early 2025Announced Collaboration with PolyNovo Ltd. Providing Introduction to Australian MarketContinued Progress in Handheld Burn Wound GlobeNewswire ? 2 months ago MDAI +2.08% MDAIW -8.44% Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M??for Military Field Use Poster Presentation at 2024 Military Health System Research SymposiumDALLAS, July 31, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced continuing progress in the development of DeepView SnapShot? M, a handheld diagnostic tool targeted for use in battlefield burn assessment that is based on the Company’s A GlobeNewswire ? 3 months ago MDAI +2.08% MDAIW -8.44% Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call DALLAS, July 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2024 on Monday, August 12, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discu GlobeNewswire ? 3 months ago MDAI +2.08% MDAIW -8.44% Spectral AI adds three southern US sites to AI burn assessment study The pivotal study is evaluating DeepView’s algorithms and their ability to assess burn healing potential. Clinical Trials Arena ? 3 months ago MDAIW -8.44% Spectral AI Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of its AI-Driven DeepView System DALLAS, July 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a 30% increase in its patent portfolio that strengthens and protects its proprietary, AI-driven DeepView System wound assessment platform. Total patents granted to the Company increased to 26 through July 8, 2024 from 20 at December 31, 202 GlobeNewswire ? 3 months ago MDAI +2.08% MDAIW -8.44%
